Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Trethera has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
Trethera's investors include National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Eye Institute, National Institute of Diabetes and Digestive and Kidney Diseases.
Trethera is headquartered in Beverly Hills, United States.
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Trethera is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trethera — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/trethera. Accessed July 19, 2026.
VCBacked. (2025). Trethera — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/trethera
{{cite web |title=Trethera — Funding & Investors |url=https://www.vcbacked.co/company/trethera |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated